RCRachana Chibber

Rachana Chibber

*This is an algorithmically generated author record based on publicly available information.

Rachana Chibber has a total of 1 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Unexplained antepartum fetal deaths: what are the determinants?

    by Rachana Chibber

    Objective The objective was to assess fetal, antenatal, and pregnancy determinants of unexplained antepartum fetal death. Methods This is a hospital-based cohort study of 34,394 births weighing 500 g or more from January 1995 to December 2002. Unexplained fetal deaths were defined as fetal deaths occurring before labor, without evidence of significant fetal, maternal or placental pathology. Results Ninety-eight unexplained antepartum fetal deaths accounted for 27.2% of 360 total fetal deaths. Two-thirds of these deaths occurred after 36 weeks’ gestation. The following factors are independently associated with unexplained fetal deaths: primiparity (OR 1.74; 95% CI 1.21, 2.86); parity of five or more (OR 1.19; 95% CI 1.26, 3.26); low socioeconomic status (OR 1.22; 95% CI 1.14, 2.86); maternal age 40 years or more (OR 3.62; 95% CI 1.22, 4.52); maternal age of 18 years or less (OR 1.79; 95% CI 0.82, 2.89); maternal prepregnancy weight greater than 70 kg (OR 2.20; 95% CI 1.85, 3.68); fewer than three antenatal visits in women whose fetuses died at 31 weeks or more (OR 1.11; 95% CI 1.08, 2.48); birth weight ratio (defined as ratio of birth weight to mean birth weight for gestational age) between 0.85 and 0.94 (OR 1.77; 95% CI 1.28, 4.18) or over 1.45 (OR 2.92; 95% CI 1.75, 3.21); trimester of first antenatal visit. Previous fetal death, previous abortion, cigarette smoking, fetal sex, low maternal weight, fetal-to-placenta weight, and post date pregnancy were not significantly associated with unexplained fetal deaths. Conclusion Several factors were identified that are associated with an increased risk of unexplained fetal deaths.


  • Child-bearing beyond age 50: pregnancy outcome in 59 cases ?a concern??

    by Rachana Chibber

    Objective To study maternal and perinatal outcomes in healthy women aged 50 years and older. Method This study was of 59 clinical pregnancies, of which 10 ended in first trimester spontaneous miscarriage (and were excluded from further studies) and 58 live births. This retrospective review of 58 live births in 49 essentially healthy women (mean [SE] age, [52±2.5] years; range 50–55 years), with no chronic medical conditions (of which 28 were primigravids). Pregnancy outcomes were ascertained by chart review and telephone follow-up. Results Of the 58 live births, 41 were singletons, and 7 were twins, and 1 triplet, for which the mean±SE gestational age at delivery were 38.1 weeks ±0.4, 36.2 weeks ±0.1 and 34.1 weeks respectively. Birth weights (mean ± SE) were 3,201 g±10, 2,252 g±4 and 1,998±95 g respectively. Mean Apgar score ± SE at 1 and 5 min were 9.2±0.8 and 8.8±0.6 respectively. Total cesarean deliveries were 73% (36/49). Of singletons 68% (28) were delivered by cesarean section as were all multiples. The incidence of pre-eclampsia was 30.6%: mild pre-eclampsia 20.4% (10/49), severe pre-eclampsia 10.2% (5/49). Gestational diabetes required insulin in all 19.5% of women. Anemia was noted in 6.5%. Conclusions Appropriately screened women, aged 50 years or older, can deliver successfully. During pregnancy, they appear to be at increased risk of pre-eclampsia and gestational diabetes. A significant majority can expect to deliver via cesarean.


  • Birth outcomes in perinatally HIV-infected adolescents and young adults in Manipur, India: a new frontier

    by Rachana Chibber, Ashok Khurranna

    Objective The objective was to study birth outcomes in perinatally HIV infected adolescents and young adults. Method Between January 1997 and January 2001, 30 asymptomatic perinatally HIV-infected primigravid pregnancies (Group A, study group) were identified amongst perinatally HIV-infected adolescents and young adults. They were attending the high-risk antenatal clinic at the Government Hospital, Manipur. Pregnancy and birth outcome were assessed. The control group (Group B) consisted of 28 perinatally infected females with no history of pregnancy. Both groups, of tribal origin, were matched for age ≤1 of the age of the pregnant females: median age 18 years (range: 16–22 years) and socio-economic class, (lower middle socio-economic class). Results The median viral load of the pregnant women were 16,383 copies/ml (range 5,251–65,571 copies/ml) and median CD4 count was 220 cells/mm3 (range: 18–980 cells/mm3. Twenty-seven (90%) of the 30 pregnant women received antiretroviral therapy (ARV) consistently during the pregnancy. Among the 30 pregnancies, 4 ended in elective abortion. The remaining 26 women delivered 26 live born infants (of these, one was a preterm delivery (35.2 weeks). There was no IUFD, IUGR, spontaneous miscarriages, or fetal, infant or maternal deaths. Conclusion Pregnancy in perinatally HIV-infected adolescents and young adults, does not appear to be associated with adverse maternal or fetal outcome if retroviral therapy is taken consistently prior and during the pregnancy. Counseling with respect to sexual activities, pregnancy and birth control is mandatory.